Latest publication
Nivolumab for advanced melanoma: A comparison of clinical outcomes for patients treated with a flat dose or weight-adjusted dose
- By Iona Campo Le Brun,
- Stephane Dalle,
- Laurent Mortier,
- Olivier Dereure,
- Sophie Dalac Rat,
- Caroline Dutriaux,
- Marie-Thérèse Leccia,
- Delphine Legoupil,
- Henri Montaudie,
- Julie De Quatrebarbes,
- Caroline Gaudy-Marqueste,
- Eve Maubec,
- Philippe Saiag,
- Cecile Pagès,
- Florence Brunet-Possenti,
- Florence Granel-Brocard,
- Raphaël Porcher,
- Wendy Lefevre,
- Céleste Lebbé
- and Emmanuelle Kempf
In Innovations & Thérapeutiques en Oncologie (2024/3 Volume 10)
Co-authors
Articles
Nivolumab for advanced melanoma: A comparison of clinical outcomes for patients treated with a flat dose or weight-adjusted dose
- By Iona Campo Le Brun,
- Stephane Dalle,
- Laurent Mortier,
- et al.
In Innovations & Thérapeutiques en Oncologie (2024/3 Volume 10)
Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database
- By Stephane Dalle,
- Emilie Varey,
- Jean-Michel Nguyen,
- et al.
In European Journal of Dermatology (2020/4 Vol. 30)